Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells
- 1 January 2008
- journal article
- review article
- Published by Informa UK Limited in Leukemia & Lymphoma
- Vol. 49 (3), 410-426
- https://doi.org/10.1080/10428190701824569
Abstract
Antifolates are the first class of antimetabolites introduced to clinic about 6 decades ago. Now, after several years of administration of antifolates against malignancies and particularly leukemia, we are still trying to achieve a full understanding of the mechanisms of action and resistance to these agents. The present article covers different factors able to influence efficacy of antifolates on leukemic cells, the known mechanisms of resistance to methotrexate (MTX) and strategies to overcome these mechanisms. The dominant factors that are contributed to tolerance to cytocidal effects of MTX including pharmacokinetic factors, impaired transmembrane uptake as the most frequent rote of provoking resistance to MTX, augmented drug efflux, impaired intracellular polyglutamation as a determining process of drug efficacy, alterations in expression or activity of target enzymes and increased intracellular folate pools; and finally role of 7-hydroxymethotrexate on response or resistance to MTX will be discussed in more detail. Finally, strategies to overcome resistance to antifolates are discussed.Keywords
This publication has 92 references indexed in Scilit:
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Amplification and organization of dihydrofolate reductase genes in a human leukemic cell line, K-562, resistant to methotrexateBiochemistry, 1983
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- No Increase in Second Tumors after Cytotoxic Chemotherapy for Gestational Trophoblastic TumorsNew England Journal of Medicine, 1983
- Anion exchange mechanism for transport of methotrexate in L1210 cellsBiochemical and Biophysical Research Communications, 1981
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977
- Methotrexate hepatotoxicity in children with leukemiaThe Journal of Pediatrics, 1977
- On the nature of permeability of sarcoma-180 cells to amethopterin in vitroBiochimica et Biophysica Acta (BBA) - Biophysics including Photosynthesis, 1965
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948
- THE CONCENTRATION OF “FOLIC ACID”Journal of the American Chemical Society, 1941